Mode
Text Size
Log in / Sign up

Nicotinamide Riboside Injections Are Safe But Cause Mild Pain

Share
Nicotinamide Riboside Injections Are Safe But Cause Mild Pain
Photo by Diana Polekhina / Unsplash

Nicotinamide Riboside Injections Are Safe But Cause Mild Pain

Imagine waking up with stiff muscles after a workout. Now picture having to take a shot just to feel better. This is the reality for many people seeking new ways to support their health. Recent research offers fresh hope for those who cannot use daily pills.

Doctors have long known that our bodies need a specific molecule called NAD+ to function well. This molecule helps cells produce energy and repair damage. As we age, our natural NAD+ levels drop significantly. This decline is linked to many age-related health problems.

For years, scientists have studied a substance called Nicotinamide Riboside. This substance helps boost NAD+ levels in the body. Oral pills work well for many people. But some patients cannot swallow pills or need faster results. This is where injections come into play.

Two small pilot studies recently tested these injections. Researchers wanted to know if they were safe. They also wanted to see how people felt after receiving the shots. The results provide important information for patients and doctors alike.

A New Way To Deliver The Drug

The first study looked at three different ways to give the drug. Doctors tested shots into the muscle, veins, and under the skin. They also compared the drug to a placebo and a different molecule.

The second study focused on two doses. Participants received either a lower or higher amount of the drug. Some got shots in the clinic while others learned to do it themselves at home.

Both studies involved healthy adults. Participants received the injections for three days. Then they had a week off before the next phase. Everyone completed the study without dropping out.

Safety was the main focus of these trials. Doctors monitored heart rate, blood pressure, and blood chemistry. They also watched for any unexpected side effects. The good news is that no serious problems occurred.

Vital signs stayed stable throughout the trials. Blood tests showed no dangerous patterns. The drug did not cause heart issues or liver damage. This is a major step forward for patients who need reliable treatment options.

However, the experience of getting the shot was not perfect. Many participants felt pain shortly after the needle went in. Muscle soreness was also very common. About 46 percent of people felt pain lasting more than two minutes.

Muscle tightness affected about 43 percent of participants. These feelings happened regardless of the dose or injection site. The discomfort was mild but noticeable. Most people could still function normally despite these feelings.

Understanding The Side Effects

Why did so many people feel sore? The body reacts to any injection. The needle itself causes some irritation. The drug solution can also cause local inflammation. This is a normal reaction to introducing a new substance into the tissue.

The pain usually fades within a few hours. It does not last for days like some other treatments might. Patients can manage this discomfort with rest or simple pain relief if needed. The benefits of raising NAD+ levels likely outweigh these temporary feelings.

This research suggests that injections are a viable option for some patients. People who struggle with pills might find this route helpful. It could also help those who need quick results for a specific condition.

You should talk to your doctor before trying this. They can explain if it fits your health needs. Not everyone needs injections. Daily pills remain the standard choice for most people.

Doctors recommend continuing to monitor blood markers. Larger studies will help confirm these early findings. We need more data to understand long-term effects. This will help guide future treatment decisions.

These trials were small and short. They were designed to check safety first. Now researchers will look at effectiveness in larger groups. Future studies will involve more participants and longer timeframes.

We do not know exactly when this treatment will become widely available. Regulatory approval takes time and more testing. Scientists are already planning the next steps in this research path.

The journey from lab to clinic is never fast. But every step brings us closer to better options. Patients deserve safe and effective choices for their health. This research moves us forward in that goal.

Share
More on NAD+